Showing 681 - 700 results of 234,822 for search '(( 10 ((mg decrease) OR (mean decrease)) ) OR ( 10 ((we decrease) OR (a decrease)) ))', query time: 1.71s Refine Results
  1. 681
  2. 682
  3. 683
  4. 684
  5. 685
  6. 686
  7. 687
  8. 688
  9. 689
  10. 690

    The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of non-caloric saccharin solution. by Pia Steensland (362091)

    Published 2013
    “…<p>Ezlopitant (5 and 10 mg/kg) significantly decreased consumption of the non-caloric 0.2% saccharin solution compared to vehicle. …”
  11. 691

    The NK1-receptor antagonist ezlopitant significantly and selectively decreases voluntary intake of both sucrose and ethanol. by Pia Steensland (362091)

    Published 2013
    “…<p>Ezlopitant decreased consumption of 5% sucrose (<b>A</b>), whereas only the highest dose of ezlopitant (10 mg/kg) decreased consumption of 20% ethanol (<b>B</b>). …”
  12. 692

    <i>In vivo</i> treatment with entinostat decreases Foxp3 expression in Tregs and inhibits Tregs function. by Li Shen (110858)

    Published 2012
    “…Cells were harvested from spleens and lymph nodes. A, <i>In vivo</i> entinostat treatment decreased the expression level of Foxp3 in CD4<sup>+</sup>Foxp3<sup>+</sup> (Treg) cells. …”
  13. 693
  14. 694
  15. 695
  16. 696
  17. 697
  18. 698
  19. 699

    GW788388 administration at 3 dpi decreased parasitemia and heart inflammatory infiltrates and increased survival rates. by Fabiane L. de Oliveira (158730)

    Published 2012
    “…<p>Male Swiss mice were injected IP with 10<sup>4</sup> bloodstream trypomastigotes. Then GW788388 (3 mg/kg) or DMSO was administered by gavage at 3 dpi. …”
  20. 700